More efficient advance strategy for Chinese market urged

Published: 2002-06-17 06:57:00

Updated: 2002-06-17 06:57:00

Yeo Hwan-jin, director of MKP & Tec Co., explained more efficient advance strategy for Chinese market at a recent seminar of the development of drug intermediates and pharmaceutical bulk drugs at on May 12 under the auspice of the New Drug Research Institute.

Director Yeo said that any decisio...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK